Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Aurora Biosciences

This article was originally published in The Gray Sheet

Executive Summary

Aurora Biosciences: Files registration statement with the Securities and Exchange Commission for an initial public offering of 3 mil. shares to be priced at $9-11 each. The San Diego-based firm is developing fluorescent assay technologies and an ultra-high throughput screening system. Proceeds from the offering would be used to expand facilities, purchase capital equipment, build up R&D and acquire chemical libraries, as well as to increase working capital and for other general corporate purposes. Alex. Brown & Sons is lead manager for the offering; Hambrecht & Quist and Robertson, Stephens & Company are co-managing...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007784

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel